Journal
Lancet Global Health
Publication Date
1-1-2022
Volume
10
Issue
1
First Page
42
Document Type
Open Access Publication
DOI
10.1016/S2214-109X(21)00448-4
Rights and Permissions
Reis G, Dos Santos Moreira-Silva EA, Silva DCM, Thabane L, Milagres AC, Ferreira TS, Dos Santos CVQ, de Souza Campos VH, Nogueira AMR, de Almeida APFG, Callegari ED, de Figueiredo Neto AD, Savassi LCM, Simplicio MIC, Ribeiro LB, Oliveira R, Harari O, Forrest JI, Ruton H, Sprague S, McKay P, Glushchenko AV, Rayner CR, Lenze EJ, Reiersen AM, Guyatt GH, Mills EJ; TOGETHER investigators. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial. Lancet Glob Health. 2022 Jan;10(1):e42-e51. doi: 10.1016/S2214-109X(21)00448-4. Epub 2021 Oct 28. Erratum in: Lancet Glob Health. 2022 Apr;10(4):e481. Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license.
Recommended Citation
Reis, Gilmar; Lenze, Eric J; Reiersen, Angela M; and et al, "Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: The TOGETHER randomised, platform clinical trial." Lancet Global Health. 10, 1. 42 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11523
Portuguese translation of the abstract.
1-s2.0-S2214109X21004484-mmc2.pdf (264 kB)
Supplementary appendix 2.
1-s2.0-S2214109X2200081X-main.pdf (44 kB)
Correction
